BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 3.866
AS - Asia 2.903
EU - Europa 1.146
SA - Sud America 679
AF - Africa 94
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 8.699
Nazione #
US - Stati Uniti d'America 3.671
SG - Singapore 1.341
CN - Cina 627
BR - Brasile 539
IT - Italia 471
VN - Vietnam 317
IN - India 280
SE - Svezia 145
DE - Germania 144
CA - Canada 142
HK - Hong Kong 131
GB - Regno Unito 91
FI - Finlandia 63
AR - Argentina 55
NL - Olanda 42
BD - Bangladesh 35
MX - Messico 31
RU - Federazione Russa 28
RO - Romania 27
EC - Ecuador 26
ID - Indonesia 26
FR - Francia 25
ES - Italia 23
IQ - Iraq 22
PL - Polonia 22
ZA - Sudafrica 20
JP - Giappone 18
UA - Ucraina 18
CL - Cile 17
CO - Colombia 14
EG - Egitto 14
MA - Marocco 13
PK - Pakistan 13
TR - Turchia 13
IR - Iran 12
VE - Venezuela 11
AT - Austria 10
TN - Tunisia 10
UZ - Uzbekistan 9
KE - Kenya 8
PY - Paraguay 8
AU - Australia 7
JO - Giordania 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
IL - Israele 6
SN - Senegal 6
DZ - Algeria 5
PE - Perù 5
TH - Thailandia 5
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
NG - Nigeria 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
LB - Libano 2
ML - Mali 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
SI - Slovenia 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
Totale 8.688
Città #
San Jose 708
Singapore 462
Dallas 379
Ashburn 345
Santa Clara 265
Bengaluru 222
Hefei 222
Chandler 212
Milan 186
Lawrence 171
Princeton 171
Hong Kong 129
Ho Chi Minh City 122
Wilmington 117
Ottawa 106
Beijing 102
Munich 102
Council Bluffs 97
Hanoi 59
São Paulo 56
Boardman 53
Los Angeles 52
London 42
Des Moines 38
Turku 38
Chicago 35
New York 32
Helsinki 25
Rome 21
Rio de Janeiro 20
Warsaw 19
Amsterdam 17
Boston 17
Naples 17
Da Nang 16
Orem 16
Tokyo 16
Chennai 15
San Francisco 15
The Dalles 15
Brasília 14
Brooklyn 14
Mexico City 14
Catanzaro 13
Guayaquil 13
Norwalk 13
Redmond 13
Columbus 12
Johannesburg 12
Biên Hòa 11
Haiphong 11
Timisoara 11
Bari 10
Crotone 10
Guangzhou 10
Guarulhos 10
New Delhi 10
Seattle 10
Stockholm 10
Atlanta 9
Jakarta 9
Manchester 9
Montreal 9
Palermo 9
Phoenix 9
Pune 9
Baghdad 8
Charlotte 8
Hải Dương 8
Ninh Bình 8
Shibin al Kawm 8
Tashkent 8
Ankara 7
Erbil 7
Florence 7
Nairobi 7
Redwood City 7
Santo André 7
Thái Bình 7
Ann Arbor 6
Asunción 6
Buenos Aires 6
Campinas 6
Cosenza 6
Dakar 6
Goiânia 6
Osasco 6
Quito 6
Salvador 6
São Bernardo do Campo 6
Toronto 6
Tunis 6
Washington 6
Amman 5
Belo Horizonte 5
Bình Dương 5
Curitiba 5
Denver 5
Joinville 5
Lamezia Terme 5
Totale 5.252
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 127
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 119
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 88
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 87
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 81
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. 78
A brief "update" on renal effects of caffeine 77
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 76
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 75
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 71
Erratum: Exercise in patients on dialysis: A multicenter, randomized clinical trial (Journal of the American Society of Nephrology (2017) 28 (1259–1268) DOI: 10.1681/ASN.2016030378) 71
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 69
[AVP: a new target in the treatment of chronic kidney disease?] 69
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 67
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 67
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 66
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 66
Renal denervation for resistant hypertension 66
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 64
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 63
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 62
Aldosterone antagonists for preventing the progression of chronic kidney disease 62
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 61
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 61
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 61
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 60
[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology] 60
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide 60
Hyperkalemia in CKD: an overview of available therapeutic strategies 60
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 59
Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment 59
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 59
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 58
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 58
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 56
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 55
Erythropoietin and its lost receptor 55
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care] 55
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 55
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 55
Development of a Wearable Device for Arteriovenous Fistula Monitoring 54
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all 54
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 53
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 53
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 53
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools 52
Aquaretic-induced apoptosis: A cure or a curse? 52
Aquaretic agents: What's beyond the treatment of hyponatremia? 51
Acute cardiovascular complications of hemodialysis 51
Glitazones in chronic kidney disease: Potential and concerns 51
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 50
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 50
Childhood Obesity: Insight into Kidney Involvement 49
Dialysis and the Elderly: An Underestimated Problem 49
Study designs adopted in epidemiology of chronic diseases 49
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 48
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 48
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 48
[Erythropoietin: pleiotropic actions] 48
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial 47
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis 47
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 47
Genomic damage in endothelial progenitor cells from uremic patients 47
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 47
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 46
Immunosuppressive Therapy, Puberty and Growth Outcomes in Pediatric Kidney Transplant Recipients: A Pragmatic Review 46
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 46
Malnutrition in the elderly patient on dialysis 45
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 45
Caffeine and the kidney: What evidence right now? 45
Neutrophil Gelatinase-associated Lipocalin in the Cardio–Renal Axis – Pathogenic Factor or Just a Risk Biomarker? 45
[The future of the European nephrology belongs to the young: the Young Nephrologists' Platform] 45
Oxidative stress and kidney function: a brief update 45
Baroreflex stimulation for treating resistant hypertension: Ready for the prime-time? 44
The aging kidney revisited: A systematic review 44
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 44
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients 43
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. 43
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 43
Physical excercise programs in CKD: lights, shades and perspectives: a position paper of the “Physical Exercise in CKD Study Group” of the Italian Society of Nephrology 43
Good-quality research in rare diseases: trials and tribulations 43
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 43
Smoking habit as a risk amplifier in chronic kidney disease patients 43
Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease 42
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study 42
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization 42
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R) 42
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 42
A new therapy for kidney injury: regeneration 42
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 42
Study designs adopted in epidemiology of chronic diseases 42
Neurobiological model and quality of life in discovering personality of the uremic patient 41
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life 41
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 41
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 41
[TNF-alpha receptors (TNFRS): the biomarkers of progressive diabetic nephropathy we were waiting for?] 41
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases 41
Delirium accompanies kidney dysfunction in hospitalized elderly patients 40
Selenoprotein-P1 (SEPP1) Expression in Human Proximal Tubule Cells after Ischemia-Reperfusion Injury: An In Vitro Model 39
Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease 39
Totale 5.457
Categoria #
all - tutte 91.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 7 2 1
2021/2022452 17 1 3 86 59 5 18 120 29 25 85 4
2022/2023869 344 99 17 38 54 43 13 55 100 28 57 21
2023/2024533 74 41 43 39 42 89 25 47 25 45 28 35
2024/20252.115 312 70 54 132 145 349 49 63 240 62 231 408
2025/20264.643 252 582 627 775 480 167 514 248 666 332 0 0
Totale 8.974